Community Research and Development Information Service - CORDIS

FP7

NEOSTREP

Project reference: 601743
Funded under: FP7-HEALTH

Development of Group B Streptococcal vaccine to alleviate emerging antibiotic resistance through elimination of current prophylactic antibiotic strategies in GBS prevention [Print to PDF] [Print to RTF]

From 2013-07-01 to 2016-06-30, ongoing project | NEOSTREP Website

Project details

Total cost:

EUR 7 969 300

EU contribution:

EUR 5 999 172

Coordinated in:

Sweden

Call for proposal:

FP7-HEALTH-2013-INNOVATION-2

Funding scheme:

CP-FP - Small or medium-scale focused research project

Objective

Related information

Coordinator

LUNDS UNIVERSITET
Sweden

EU contribution: EUR 1 050 734,5


Paradisgatan 5c
LUND, Sweden
Administrative contact: Stina Ahlenius
Tel.: +46 46173465
Fax: +46 46130064
E-mail

Participants

MINERVAX APS
Denmark

EU contribution: EUR 3 124 600


VEDBENDVEJ 28
HELLERUP, Denmark
Administrative contact: Per Fischer
Tel.: +45 20252038
E-mail
BIO-KINETIC EUROPE LIMITED
Ireland

EU contribution: EUR 1 624 077


GREAT VICTORIA STREET 14
BELFAST, Ireland
Administrative contact: Crawford Maclean
Tel.: +44 2890818381
Fax: +44 2890238123
E-mail
CITOXLAB SCANTOX AS
Denmark

EU contribution: EUR 199 760,5


Hestehavevej 36A
Lille Skensved, Denmark
Administrative contact: Andrew Makin
Tel.: +45 56 86 15 26
Fax: +45 56 92 12 02
E-mail

Subjects

Life Sciences
Record Number: 108885 / Last updated on: 2015-03-11